Eloquest Healthcare and Onset Therapeutics to co-promote Optase

Eloquest Healthcare is partnering with Onset Therapeutics to co-promote Optase.
The gel delivery system promotes healing in the treatment of decubitus ulcers,
varicose ulcers and dehiscent wounds, according to Onset.